Efficacy and safety of NAD+ ADP-ribosyltransferase 1 agonist versus Donepezil in elderly Chinese patients with Alzheimer disease:  A novel target for effective therapy

Jianhong Wang; Shu Yang; Zicheng Hu; Haimei Yang; Dong Wei; Duozi Wang; Fuqiang Guo

doi:10.36721/PJPS.2019.32.5.SP.2427-2432.10

original articles

Efficacy and safety of NAD+ ADP-ribosyltransferase 1 agonist versus Donepezil in elderly Chinese patients with Alzheimer disease: A novel target for effective therapy

Jianhong Wang, Shu Yang, Zicheng Hu, Haimei Yang, Dong Wei, Duozi Wang, Fuqiang Guo

Vol. 32

Issue 5

Pages 2427-2432

Published 25 Sept 2019

DOI: 10.36721/PJPS.2019.32.5.SP.2427-2432.10

Authors Abstract Related

Authors & Affiliations

Jianhong Wang

Shu Yang

Zicheng Hu

Haimei Yang

Dong Wei

Duozi Wang

Fuqiang Guo

Abstract

This pilot study designed to evaluate the efficacy and safety of NAD+ ADP-ribosyl transferase 1 (NART) agonist in comparison with Donepezil

Keywords

NAD+ ADP-ribosyltransferase agonist

donepezil

Alzheimer disease

Chinese elderly

Metrics

PlumX Metrics

original articles

Efficacy and safety of NAD+ ADP-ribosyltransferase 1 agonist versus Donepezil in elderly Chinese patients with Alzheimer disease: A novel target for effective therapy

Jianhong Wang, Shu Yang, Zicheng Hu, Haimei Yang, Dong Wei, Duozi Wang, Fuqiang Guo

Vol. 32

Issue 5

Pages 2427-2432

Published 25 Sept 2019

DOI: 10.36721/PJPS.2019.32.5.SP.2427-2432.10

Authors Abstract Related

Authors & Affiliations

Jianhong Wang

Shu Yang

Zicheng Hu

Haimei Yang

Dong Wei

Duozi Wang

Fuqiang Guo

Abstract

This pilot study designed to evaluate the efficacy and safety of NAD+ ADP-ribosyl transferase 1 (NART) agonist in comparison with Donepezil

Keywords

NAD+ ADP-ribosyltransferase agonist

donepezil

Alzheimer disease

Chinese elderly

Metrics

PlumX Metrics

Efficacy and safety of NAD+ ADP-ribosyltransferase 1 agonist versus Donepezil in elderly Chinese patients with Alzheimer disease: A novel target for effective therapy

Authors & Affiliations

Abstract

Keywords

Metrics

Indexed & Abstracted in Leading Databases

Efficacy and safety of NAD+ ADP-ribosyltransferase 1 agonist versus Donepezil in elderly Chinese patients with Alzheimer disease: A novel target for effective therapy

Authors & Affiliations

Abstract

Keywords

Metrics